Abacus dx welcomes TriLink BioTechnologies
Abacus dx is pleased to announce a new partnership with TriLink BioTechnologies, known globally as “The Modified Nucleic Acid Experts™”.
TriLink BioTechnologies has appointed Abacus dx as their new exclusive distributor in Australia and New Zealand for both catalogue and custom orders.
TriLink BioTechnologies specializes in the synthesis of highly modified nucleic acid constructs for research, diagnostic, and therapeutic applications. Since 1996, TriLink has offered cutting edge products to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy, next generation sequencing, vaccines, and diagnostics.
TriLink develops and manufactures:
- mRNA transcripts
- custom chemistry
- solutions for PCR & RT-PCR, and
- NGS library preparation kits
The oligonucleotide and mRNA solutions offered have enabled significant advancements in the biological sciences.
Together, both TriLink BioTechnologies and Abacus dx look forward to providing the market with industry-leading reagents and technology, consistent high quality, and ready access to expert scientific support when needed.
For all technical enquiries or for further information on the best solution for your specific applications, please click here to speak with a representative.